NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/14/2026
Back to search
Official data from USPTO
REPHINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
05/15/2026
Trademark type
Word
Nice classes
42, 45
Filing date
06/07/2022
Registration date
04/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/30/2024
Last transaction
05/15/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
LOZEAU, BRANDON THOMAS
Law office
N90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Rephine Limited
Representatives
Michael J. Brown Michael J Brown Law Office LLC
Technical classification
Nice Classes
Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical product evaluation; quality audits in the nature of product quality evaluation; product quality control testing; product safety testing services; testing services in the field of manufacturing safety; quality assurance consultancy in the field of pharmaceuticals and the manufacture of pharmaceuticals; inspection services of pharmaceuticals and manufacturing processes for pharmaceuticals for quality control; inspection of manufacturing processes to determine conformance with certification standards for qualityreliabilitysafety; inspection of pharmaceuticals; product quality testing services; testing of pharmaceuticals; quality control for others to determine conformance with established product certification standards; product quality evaluation services in the nature of quality control for others; industrial analysis services in the field of pharmaceuticals and manufacturing processes for pharmaceuticals; testinginspectionquality controlevaluationverification and analysis of medical products and pharmaceuticals for others; testinginspectionquality controlverificationevaluation and analysis of medical products and pharmaceuticals for others for compliance with quality standards; testingquality control inspectionevaluationverification and analysis of quality management systemsmanufacturing systemsmanufacturing methods and manufacturing processes; conducting clinical trials for others; scientific research in the nature of scientific study protocol development; research and development in the pharmaceutical field; informationadvisory and consultancy services in relation to the aforesaid
Class 45
Regulatory compliance auditing; legal compliance auditing; good manufacturing practices audit in the nature of legal compliance auditing; advisory services relating to regulatory affairs in the field of the manufacture of pharmaceuticals; reviewing standards and practices to assure compliance with manufacturing process safetyproduct safety and product packaging laws and regulations; legal and regulatory information services relating to pharmaceutical manufacturing standards; analysis of datapolicy and processprovision of advice and assistance relating to standards and practices to ensure compliance with manufacturing process safetyproduct safety and product packaging laws and regulations; legal and regulatory compliance consulting services in the field of the manufacture of pharmaceuticals; legal and regulatory advisory and consultancy services in relation to clinical trials; provision of information and advice relating to regulatory compliance systems in the field of the manufacture of pharmaceuticals; legal serviceslegal risk assessment services for the security of goods and individuals; project management consulting services relating to regulatory compliance requirements for pharmaceutical manufacturing safety and security; regulatory compliance consulting in the field of the manufacture of pharmaceuticalsprovision of benchmarking and reference information relating to pharmaceutical safety standards; informationadvisory and consultancy services in relation to the aforesaid
Publications
History of USPTO decisions and trademark events.
46 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/17/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/26/2024
FIMP
FINAL DISPOSITION PROCESSED
10/26/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/30/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/29/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/10/2024
GPNX
NOTIFICATION PROCESSED BY IB
02/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/13/2024
PUBO
PUBLISHED FOR OPPOSITION
02/13/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/24/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/24/2024
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/10/2024
ALIE
ASSIGNED TO LIE
01/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/22/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
11/22/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/22/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
11/22/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/22/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/14/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
09/14/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/14/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
09/14/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/14/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/17/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/17/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/17/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/17/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/21/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2023
RFNT
REFUSAL PROCESSED BY IB
06/18/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/01/2023
RFRR
REFUSAL PROCESSED BY MPU
06/01/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/04/2023
CNRT
NON-FINAL ACTION WRITTEN
04/03/2023
DOCK
ASSIGNED TO EXAMINER
03/22/2023
MAFR
APPLICATION FILING RECEIPT MAILED
11/18/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/14/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/10/2022
Continuous trademark protection
Get notified about every new filing that threatens REPHINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.